chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had clear discharge from my nose on 18Apr2022 and I tested positive for COVID with an antigen test. The discharge just lasted a day and I tested negative for COVID on 23Apr2022.; I had clear discharge from my nose on 18Apr2022 and I tested positive for COVID with an antigen test. The discharge just lasted a day and I tested negative for COVID on 23Apr2022.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 06Apr2021 at 12:00 as dose 1, single (Lot number: EW0150), in right arm, on 27Apr2021 at 12:00 as dose 2, single (Lot number: EW0176), in right arm and on 27Oct2021 at 12:00 as dose 3 (booster), single (Lot number: FF8841) at the age of 65 years, in right arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 19Mar2022 at 15:30 as dose 4 (booster), single (Lot number: EW0176), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Allergic to penicillin" (unspecified if ongoing), notes: Allergic to penicillin and I am lactose, intolerant; "lactose intolerant" (unspecified if ongoing), notes: Allergic to penicillin and I am lactose, intolerant. Concomitant medication(s) included: VITAMIN D3, start date: 09Feb2017. The following information was reported: DRUG INEFFECTIVE (medically significant), 5 years 2 months 9 days 12 hrs 45 min after the suspect product(s) administration, outcome "unknown", COVID-19 (medically significant), 5 years 2 months 9 days 12 hrs 45 min after the suspect product(s) administration, outcome "recovered" and all described as "I had clear discharge from my nose on 18Apr2022 and I tested positive for COVID with an antigen test. The discharge just lasted a day and I tested negative for COVID on 23Apr2022.". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (18Apr2022) positive; (23Apr2022) negative. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Additional information: Antiviral details product: COVID 19 Treatment, brand: Paxlovid. Treatment start date: 31Mar2022, Treatment stop date: 04Apr2022, Indication: Treatment of COVID-19. Adverse event: Consumer had clear discharge from her nose on 18April2022 and she tested positive for COVID with an antigen test. The discharge just lasted a day and she tested negative for COVID on 23April2022.
r rash spreading underneath her arm and approaching the elbow; Rash on her chest; Hard around injection site; Painful around injection site; Ache on the shoulder; Arm swollen around injection site; Hot around injection site; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm swollen around injection site), VACCINATION SITE WARMTH (Hot around injection site), CONDITION AGGRAVATED (r rash spreading underneath her arm and approaching the elbow), RASH (Rash on her chest) and VACCINATION SITE INDURATION (Hard around injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to chemicals (sulfur), Allergy (FLAXEN) and Shellfish allergy.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced PERIPHERAL SWELLING (Arm swollen around injection site) and RASH (Rash on her chest). 03-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Hot around injection site), VACCINATION SITE INDURATION (Hard around injection site), VACCINATION SITE PAIN (Painful around injection site) and ARTHRALGIA (Ache on the shoulder). On 09-Mar-2021, the patient experienced CONDITION AGGRAVATED (r rash spreading underneath her arm and approaching the elbow). At the time of the report, PERIPHERAL SWELLING (Arm swollen around injection site), VACCINATION SITE WARMTH (Hot around injection site), VACCINATION SITE INDURATION (Hard around injection site), VACCINATION SITE PAIN (Painful around injection site) and ARTHRALGIA (Ache on the shoulder) had not resolved, CONDITION AGGRAVATED (r rash spreading underneath her arm and approaching the elbow) outcome was unknown and RASH (Rash on her chest) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication were reported.   Most recent FOLLOW-UP information incorporated above includes: On 14-Mar-2021: Follow up received on 14 march 2021, Reporter Email id and alternate phone number has been updated, Added allergies sulfur, Flaxen and shellfish, updated drug start date from 02-MAR-2021 to 01-MAR-2021. Added additional events rash spreading underneath her arm and rash approaching the elbow.
Patient has experience unexpected side effects/symptoms-Low Blood pressure [<120] on 04/27/2021 at 10:00-10:15 AM, caused by this vaccine, now bending a preliminary medical examination with personal physician.  Left Arm: 113- SYSTOLIC                   Right Arm: 88 SYSTOLIC                  74- DIAATOLIC                                    111 DIASTOLIC                  92- PULSE                                             90 PULSE Wrist Blood Pressure Monitor: w/ LCD Display:   ADVOCATE [Model: FT-B05W-No Voice]   Specification:-Reported Accuracy:        Pressure: 40-280mmHg        Pulse: 30-160 Pulses Also, mild fatigue due to the unexpected symp0toms of adverse effect sand  continue experiences of  dizziness, tingling sounds in the right ear  during the day/night  hours, and evening hours of chills, absent of shortness of  breath or chest pains, which present symptoms has resulted from the Pfizer-BioNTech COVID 19 Vaccine also refer4ed to as Cov19/Pfizer Second Dose [ER8734].
pt recvd vax & devel a low grade fever & felt ill for 1 to 2 days afterward; pt also had tenderness, warmth & swelling @ inject site;
Pt ran temp 102 for 1 wk, leg red & swollen; 24hrs p/inject pt quit movement of body parts; mom states can no longer roll over, can't babble, has difficulty swallowing;  MD states older sibling deceased @ 8mo of Krabbes dis;
Swelling on right thigh started out pea-sized and gradually increased, On 08/10/02, swelling was 2-3 inches across and into the groin area, so Mom took child to his private physician. Physician told mom it was a reaction to one of the vaccine. Mom called vaccine provider to report the reaction, 08/12/02 Swelling persisted at the time.
Fever, headache, shivering, fatigue, muscle pain, losing energy, slight numbness in the top of some fingers.
After my first shot I had rashes on upper front thighs, stomach, under breasts.  The same after the second shot only probably more pronounced rashes.  I still have these rashes in the same places.  I suspect the fact that I have some more seasonal mild eczema and had pityriasis rosea a couple years ago could have possibly exacerbated this reaction.  I was also more tired than usual for a couple days after both shots, but that wasn't a big deal.  I don't notice the rash sometimes, but sometimes it itches and stings.
Repeat vaccinations of Kinrix and Proquad given again on 2/18/2022
Pt recv vax on unspecified day;  post vax pt exp dizziness, vomiting, swollen feet, vax site pain
/Started feeling pain in outer portion of my shoulder, that was sporadic. Went to Dr. 07/19/2022 and was referred to Orthopedics Dr. The Orthopedic Dr. sent me to a Physical Therapist. Range of motion got better, but the pain stayed. Pain is currently stronger and starting to spread to other areas. After PT, went back to my Dr. and Dr. wants to give an MRI on 10/23/2022.
DOSE 2 FEVER, NAUSEA, EXHAUSTION, COUGH, COLD LIKE SYMPTOMS FOR 8-10 HOURS THE NEXT DAY DOSE 1 TERRIBLE WAVES OF NAUSEA 10 ON A SCALE OF 1-10 10 BEING WORST - THREE TIMES UPON WAKINGUP THAT NEXT DAY
Patient was administered Moderna as an off label administration.  No complications or adverse events reported following the 1st dose in the series. The 2nd dose in the series was administered  on 05/12/2021 with no adverse symptoms.
Fever, injection site soreness, injection site rash (non-itchy), injection site swelling.
This spontaneous report as received from a nurse refers to 30 unspecified patients received doses of GARDASIL (lot H020910, exp 18-JUN-2015) on unspecified dates, that were exposed to the same temperature excursion(28.8F for 8 minutes). No adverse effect reported. This is one of several reports received from the same source (related case #1307USA015230; 1308USA005499). Additional information has been requested.
Patient reported facial swelling after receiving vaccine, which self resolved. Patient seen in clinic 1day after receiving vaccine and no swelling noted at that time.
Pt was seen 7/2/14 given ADACEL for preventive care. On 8/7/14 she returned stating she had a "sore arm" at the ADACEL injection site. She has limited extension without pain and abduction. No history of arthritis. She returned 8/13/14 still symptomatic.
My arm wasn't sore right away but I think I laid on it and the next morning it was sore. It felt like a bee sting I took some medicine and it went away.  On the 27th I had bad gas. I did try a new cereal and thought it was cereal. On the 28th I still gas and upset stomach like flu like symptoms  and felt light headed but not bad. On the 29th still an upset stomach and had diarrhea, I was still light headed and really shaky. I was really weak. I was shaking a lot at arms (hands) and legs were both shaking  and made it hard to walk. On the 30th I still really light headed and my legs and hands were still shaky, still having difficulty walking, still had an upset stomach and still felt weak. On the 31st my stomach was a lot better, I was still shaky and light headed, and I had a weak feeling. My head felt like when you feel like you have a head cold (pressure in my head). Today my stomach is better, I am still lightheaded and still shaky but not as bad. I still feel pressure in my head, but no runny nose or any other cold symptoms.   These were symptoms I had in March when I was sick for 3 weeks. I was negative for COVID but didn't get back to my normal self until the June.   Doctor was a private practice and recently closed so I do not see my new doctor till the 24th.
Anxiety, Dizziness, Inability to Sleep, Pressure in the Head, Weak legs, Numbness in hands and feet
Chest pain; discomfort in her chest; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a 63-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in left arm on 03May2021 (Batch/Lot number was not reported) (at the age of 63 years old) as dose 2, single for COVID-19 immunisation. There were no patient's medical history and concomitant medications. The patient previously received BNT162B2 via unspecified route of administration, administered in left arm on 12Apr2021 (Batch/Lot Number: EW0162) as dose 1, single for COVID-19 immunisation. The patient reported that after second shot of the COVID vaccine she experienced a lot of chest pain. She had chest pain on 03May2021, the night after the shot. She had to have a stent put in her heart. The event required visit to Emergency Room and Physician Office. She went to the doctor trying to understand the discomfort in her chest. She went to urgent care and then lead her to the ER and to being admitted. The patient was hospitalized from the 29May2021 to the 03Jun2021, five days. No prior vaccinations (within 4 weeks). The outcome of the events was unknown.  No follow-up attempts are needed; information on Batch/Lot number cannot be obtained.
Patient came in for 2nd dose of pfizer without his vaccine card.  Staff gave 2nd dose on 5/27/2021.  He had booked appointment for 2nd appointment. Timing of vaccine not verified when staff registered him. Patient came back in to have his vaccine card filled out and and staff noticed that the 2nd dose was given on day 16.  too early for 4 day rule.
Having tingling on the left side of my face and  left leg. Feels like my leg is asleep. My face feels like after you go to the dentist and the numbing is going away. It has gotten better but still having some numbness under my left eye and inside my left nostril.
Received vaccine on 1/6/2021 at 10:30 AM. Sneezing and runny nose since 1/6/2021 10:00 PM.
erythema multiforme 31MAR996 for 3-4 days; no tx
high pressure, throat sore, ringing in the ear, pressure in the head whenever having intercourse, dizziness
The evening of the vaccination, pt complained of nausea, vomiting and headache. The following day pt developed mild swelling of both wrists and ankles.  Also stiffness to these extremities.
The patient reported increasing shortness of breath for the past few days prior to ED presentation. The patient was found to have a hemoglobin of 5 and was also found to be positive for COVID-19. The patient is experiencing a GI bleed causing the acute blood loss anemia. Patient has been started on pantoprazole and will be admitted to the hospital.
This spontaneous report as received from a nurse who refers to multiple patient's medical history and concurrent conditions were not reported. On an unspecified date in January 2016, multiple patients were vaccinated with improperly stored doses of M-M-R II lot # L020189 expiration date 03-MAR-2017, L026551 expiration date 16-JUL-2017. Dose, route and anatomical location were not provided. No other concomitant medications were reported.. Excursion details: The vaccine was exposed to 9 degree F for a total of 9 hours. Digital data logger was involved. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Around 1 am I began to feel shortness of breath/have difficulty breathing at night; cough; chest pain; wheezing; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 43 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 17Mar2022 20:00 (Lot number: FK9894) at the age of 43 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DYSPNOEA (non-serious) with onset 18Mar2022 01:00, outcome "not recovered", described as "Around 1 am I began to feel shortness of breath/have difficulty breathing at night"; COUGH (non-serious) with onset 18Mar2022 01:00, outcome "not recovered", described as "cough"; CHEST PAIN (non-serious) with onset 18Mar2022 01:00, outcome "recovered" (18Mar2022 04:00), described as "chest pain"; WHEEZING (non-serious) with onset 18Mar2022 01:00, outcome "not recovered", described as "wheezing". The events "around 1 am i began to feel shortness of breath/have difficulty breathing at night", "cough", "chest pain" and "wheezing" were evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of dyspnoea, cough, chest pain, wheezing.  Additional information: Patient had no known allergies. The patient was not diagnosed with COVID-19 prior to the vaccination. The patient had tested for COVID-19 after vaccination.  No follow-up attempts are possible. No further information is expected.
Called to report feeling itchy, no rash noted, took own supply of Benadryl
Redness, swelling and hardness of skin. Skin feels itchiy to patient. Tennis ball sized even.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 019B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Feb-2021 at 10:57 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 28-Mar-2021 at 10:51 AM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 76.44 on 28-Feb-2021 and 76.51 on 28-Mar-2021. Concomitant products were not provided. For Lot no : 014M20A on 28-Feb-2021, excursion time was 9 AM  and 1PM and temperature was 27 and 26 respectively, total doses given for the day was 152, condition of vaccine prior to vaccination was not frozen, vaccine was moved to fridge on 24-Feb-2021 was moved to clinic on 27-Feb-2021. 20 vial was sent to clinic. Vaccine BUD date was 26-Mar-2021. For Lot no : 019B21A on 28-Mar-2021, excursion time was 10 AM  and temperature was 35 respectively, total doses given for the day was 150, condition of vaccine prior to vaccination was not frozen, vaccine was moved to fridge on 23-Mar-2021 was moved to clinic on 27-Mar-2021, 15 vial was sent to clinic, Vaccine BUD date was 22-Apr-2021. For Lot no : 014M20A vial was stored on cooler 1 , on 28-Feb-2021, Excursion duration At 9 AM: 27, 10 AM: 40, 11 AM: 44, 12 AM: 46, 1PM : 26, 2 PM : 37, 3 PM: 43, 4 PM: 45. The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. Temperature recordings were taken using a traceable temperature monitor at every hour. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature. It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F. Treatment medications were not reported.
INCREASED SEIZURE ACTIVITY - TRANSPORTED TO ER VIA AMBULANCE AND ADMITTED FOR OBSERVATION
5 to 7 min p/vax pt fainted while standing @ cashier's window;head struck floor & caused a closed cranial injury requiring hosp & subsequent surgery;pt exp vasovagal syncope  which resulted in a closed head injury
BODY ACHE; NO APPETITE; NAUSEA; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and batch number: 1805018 expiry: UNKNOWN) dose was not reported, administered on 17-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 18-MAR-2021, the subject experienced body ache. On 18-MAR-2021, the subject experienced no appetite. On 18-MAR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the body ache, no appetite and nausea was not reported. This report was non-serious.
presented with client on 7/19/07. c/o five rash on both arms, chest lower back. Observed papular rash on arms, chest and lower back. Noted macular rash on both buttocks. Denies fever or itching. No irritation at injection site
tiredness; woke up dizzy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 85 year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 15Mar2021 09:00 (Batch/Lot number: unknown) at the age of 85 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious) with onset 18Mar2021, outcome "unknown", described as "woke up dizzy"; FATIGUE (non-serious), outcome "unknown", described as "tiredness".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Cellulitis; lymphangitis at 24 hours post dose, treated with antibiotics.
Tingling  right leg after second shot; Numbness right leg after second shot; High Fever (102 F) after second shot; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling  right leg after second shot), HYPOAESTHESIA (Numbness right leg after second shot) and PYREXIA (High Fever (102 F) after second shot) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008C21A and 027B21A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: ANTACID [CALCIUM CARBONATE] (Antacids prior to vaccination).   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (High Fever (102 F) after second shot). On 13-May-2021, the patient experienced PARAESTHESIA (Tingling  right leg after second shot) and HYPOAESTHESIA (Numbness right leg after second shot). On 09-May-2021, PYREXIA (High Fever (102 F) after second shot) had resolved. At the time of the report, PARAESTHESIA (Tingling  right leg after second shot) and HYPOAESTHESIA (Numbness right leg after second shot) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-May-2021, Body temperature: 102 (High) 102 Fahrenheit.         Concomitant medication was not provided Treatment information was not reported Patient has seen several doctors and has done tests that were normal.
Within 24 hours of injection, right upper arm was painful. As day went on applied cold packs and took Tylenol for discomfort. After one week of no relief, called doctor's office and was told to just continue with alternating cold and warm compresses and Tylenol as needed. On follow up appt on 7/8/21, I told Dr. my arm muscle was still aching especially when lifting over head. Told to continue what I was doing and don't overuse arm. Arm muscle would improve slightly over next couple months, then begin cramping up and pain would wake me at night. Contacted office again and told to come in for follow up. Clinic never called back to set up appt. so on Nov. 3rd, went to walk in clinic. Referred to orthopedics, on Nov. 5th where I was examined and did an x-ray and on Nov. 10th had ultrasound, Physical Therapy appt on Nov. 16th